Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Receives $11.86 Average Target Price from Brokerages
Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB – Get Free Report) has been given an average rating of “Hold” by the ten analysts that are currently covering the firm, MarketBeat Ratings reports. Two analysts have rated the stock with a sell rating, four have given a hold rating and four have assigned a buy rating to the company. […]
More Stories
Mousetrap: K-drama: Release Date, Trailer, Cast Members, and More
If you love intense drama with lots of thriller and psychological tension, then I have some good news for you....
Dylan Jagger Lee and Paula Bruss are Married! Know the Wedding Venue and Other Details
Have you also heard the news about Pamela’s son getting married? Yes, the news is correct! Dylan Jagger Lee, the...
The Map of Longing: Release Date, Cast Members, Trailer, and Synopsis
Are you ready for an emotional and loving journey between two sisters? If you are a fan of a chaotic...
Netflix has announced the Release Date for Steps, a Cinderella Spin-Off
Mark your calendar! Netflix has brought an all-new anime film, Steps, for a 2026 release. The film flips the classic...
Avatar: The Last Airbender Season 3: Release Date, Trailer, and Cast Members
Everyone’s favourite animated series, Avatar: The Last Airbender, is coming back with more action-packed visuals to captivate its audience once...
Cyberpunk: Edgerunners Season 2: Release Date, Cast, Trailer, and More
Night City is coming again with its renewal after four years of waiting. Since its first release in 2022, the...